Published in J Gen Intern Med on January 01, 2014
Improving alcohol withdrawal outcomes in acute care. Perm J (2014) 0.89
Inpatient alcohol withdrawal: time to prevent the preventable? J Gen Intern Med (2014) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Basic principles of ROC analysis. Semin Nucl Med (1978) 27.12
Index for rating diagnostic tests. Cancer (1950) 27.09
The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med (1998) 16.62
Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev (2007) 10.34
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict (1989) 6.58
Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus (2007) 4.91
The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res (2007) 4.84
Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology (2005) 4.65
Receiver operating characteristic curves and their use in radiology. Radiology (2003) 4.57
Candidate performance measures for screening for, assessing, and treating unhealthy substance use in hospitals: advocacy or evidence-based practice? Ann Intern Med (2010) 3.07
Alcohol consumption and related problems among primary health care patients: WHO collaborative project on early detection of persons with harmful alcohol consumption--I. Addiction (1993) 2.83
Receiver operating characteristic analysis: a tool for the quantitative evaluation of observer performance and imaging systems. J Am Coll Radiol (2006) 2.07
Better decisions through science. Sci Am (2000) 1.55
The science of choosing the right decision threshold in high-stakes diagnostics. Am Psychol (1992) 1.52
The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow. J Gen Intern Med (2006) 1.38
Prospective study of alcohol-related admissions in an inner-city hospital. Lancet (1986) 1.25
Diagnostic usefulness of brief versions of Alcohol Use Disorders Identification Test (AUDIT) for detecting hazardous drinkers in primary care settings. J Stud Alcohol (2005) 1.09
Applications of ROC analysis in medical research: recent developments and future directions. Acad Radiol (2012) 0.99
Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients. Alcohol Alcohol (2005) 0.95
The Alcohol Use Disorders Identification Test (AUDIT) predicts alcohol withdrawal symptoms during inpatient detoxification. J Addict Dis (2002) 0.89
Smooth semiparametric receiver operating characteristic curves for continuous diagnostic tests. Stat Med (2007) 0.85
Management of delirium tremens. J Intensive Care Med (2005) 0.83
Questionnaires are better than laboratory tests to screen for current alcohol abuse or dependence in a male inpatient population. Acta Clin Belg (2003) 0.82
The pattern of alcohol consumption of a general hospital population in north Belfast. Alcohol Alcohol (1996) 0.81
Principles and practice of detoxification. Prim Care (1993) 0.80
Alcohol withdrawal and prolonged hospital stay in a patient with neuroimaging abnormalities: a case report. Alcohol Alcohol (2009) 0.78
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction (2005) 4.14
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation (2005) 2.85
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Am J Addict (2004) 2.85
Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med (2006) 2.40
An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med (2006) 2.37
An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care (2005) 1.76
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med (2006) 1.65
"We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care (2010) 1.60
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation (2012) 1.50
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention. J Interv Cardiol (2009) 1.47
The role of head computer tomographic scans on the management of MICU patients with neurological dysfunction. J Intensive Care Med (2009) 1.44
Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care (2009) 1.43
A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. JACC Cardiovasc Interv (2009) 1.41
Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up. J Am Coll Cardiol (2004) 1.41
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes (2008) 1.40
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial. Drug Alcohol Depend (2012) 1.37
Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med (2008) 1.28
Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment. Addict Sci Clin Pract (2012) 1.23
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs? J Subst Abuse Treat (2010) 1.21
Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Arch Gen Psychiatry (2012) 1.18
Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available. Curr Psychiatry Rep (2010) 1.16
Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend (2008) 1.16
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend (2008) 1.07
Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav (2004) 1.02
Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest. J Am Coll Cardiol (2009) 1.01
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. J Am Coll Cardiol (2005) 1.01
Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation. J Subst Abuse Treat (2006) 1.00
Treatment of opioid-dependent adolescents and young adults with buprenorphine. Curr Psychiatry Rep (2009) 0.99
Electronic health record use to classify patients with newly diagnosed versus preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manag (2011) 0.98
Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. Contemp Clin Trials (2012) 0.96
Sex under the influence of drugs or alcohol: common for men in substance abuse treatment and associated with high-risk sexual behavior. Am J Addict (2010) 0.95
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. Am J Drug Alcohol Abuse (2012) 0.95
Staff beliefs about drug abuse clinical trials. J Subst Abuse Treat (2002) 0.94
Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants. Addict Behav (2013) 0.94
Dissemination and feasibility of a cognitive-behavioral treatment for substance use disorders and posttraumatic stress disorder in the Veterans Administration. J Psychoactive Drugs (2006) 0.94
An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology (2013) 0.92
All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1). Diabetes Care (2006) 0.92
Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5). Diabetes Care (2008) 0.92
Use of a uniform treatment algorithm abolishes racial disparities in glycemic control. Diabetes Educ (2008) 0.90
CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells. J Infect Dis (2005) 0.87
HIV seroprevalence among drug users: an analysis of selected variables based on 10 years of data collection in Porto Alegre, Brazil. Drug Alcohol Depend (2006) 0.87
Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record. Pharmacoepidemiol Drug Saf (2012) 0.86
Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices. Vasc Health Risk Manag (2012) 0.85
Brain injury markers (S100B and NSE) in chronic cocaine dependents. Rev Bras Psiquiatr (2007) 0.85
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemp Clin Trials (2011) 0.85
Comparative effectiveness research using electronic health records: impacts of oral antidiabetic drugs on the development of chronic kidney disease. Pharmacoepidemiol Drug Saf (2013) 0.84
The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial. Am Heart J (2006) 0.84
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina. Circ Cardiovasc Qual Outcomes (2011) 0.84
Identifying differences in communication technology preferences across the lifespan. J Am Geriatr Soc (2012) 0.84
Cardiopulmonary resuscitation inpatient outcomes in cancer patients in a large community hospital. Del Med J (2012) 0.84
Emergency department tachypnea predicts transfer to a higher level of care in the first 24 hours after ED admission. Acad Emerg Med (2010) 0.83
The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance. Prim Care Diabetes (2008) 0.83
Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: a pooled analysis of two randomized controlled trials. Subst Abuse Treat Prev Policy (2014) 0.82
Clinician validation of Poison Control Center (PCC) intentional exposure cases involving prescription opioids. Am J Drug Alcohol Abuse (2006) 0.82
Efficiency and economic benefits of a payer-based electronic health record in an emergency department. Acad Emerg Med (2010) 0.82
Comparison of recovery after mitral valve repair and replacement. J Thorac Cardiovasc Surg (2007) 0.82
Lost-to-care and engaged-in-care HIV patients in Leningrad Oblast, Russian Federation: barriers and facilitators to medical visit retention. AIDS Care (2014) 0.82
Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defines an approach to assess provider behavior. Diabetes Educ (2006) 0.81
Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS. Am J Cardiovasc Drugs (2010) 0.81
Community treatment programs take up buprenorphine. Sci Pract Perspect (2004) 0.80
Crisis intervention in a military population: a comparison of inpatient hospitalization and a day treatment program. Mil Med (2002) 0.80
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. Am Heart J (2006) 0.80
Long-term cost-effectiveness of clopidogrel in STEMI patients. Int J Cardiol (2008) 0.79
Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study. J Am Coll Cardiol (2009) 0.79
Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial. Am Heart J (2006) 0.79
Hip strength in adults with type 1 diabetes is associated with age at onset of diabetes. J Clin Densitom (2011) 0.78
Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: patterns, user characteristics, and management options. Curr Psychiatry Rep (2005) 0.78
The risk of cardiovascular events in primary care patients following an episode of severe hypertension. J Clin Hypertens (Greenwich) (2009) 0.78
Substance use disorder and its effects on outcomes in men with advanced-stage prostate cancer. Cancer (2014) 0.78
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes (2013) 0.78
Medication-assisted treatment for opioid addiction: methadone and buprenorphine. J Food Drug Anal (2013) 0.77
Frequency of severe valvular disease caused by mediastinal radiation among patients undergoing valve surgery in a community-based, regional academic medical center. Clin Cardiol (2013) 0.77
Suicidal ideation in veterans receiving treatment for opiate dependence. J Psychoactive Drugs (2006) 0.77
Antibiotic prescribing by telephone in primary care. Pharmacoepidemiol Drug Saf (2014) 0.77
Methods for the economic and quality of life supplement to the cilostazol for RESTenosis (CREST) trial. J Invasive Cardiol (2004) 0.77
Do clinical trials in ischemic heart disease meet the needs of those with ischemia? J Am Coll Cardiol (2015) 0.76
Effects of surgically induced weight loss by Roux-en-Y gastric bypass on osteocalcin. Surg Obes Relat Dis (2012) 0.76
Appropriate admissions to the appropriate unit: a decision tree approach. Am J Med Qual (2005) 0.76
Screening blood donors for diabetes: analysis of use, accuracy, and cost. Transfusion (2013) 0.76
Medication-assisted treatment for opioid dependence: making a difference in prisons. F1000 Med Rep (2011) 0.75
The globalization of addiction research: capacity-building mechanisms and selected examples. Harv Rev Psychiatry (2015) 0.75
Digital image analysis: a reliable tool in the quantitative evaluation of cutaneous lesions and beyond. Arch Dermatol (2007) 0.75
Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence. J Addict Med (2016) 0.75
Clonidine: new use of an old medication to reduce stress-related substance use. Evid Based Ment Health (2016) 0.75
Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. J Addict Med (2016) 0.75
Improving Nursing Knowledge of Alcohol Withdrawal: Second Generation Education Strategies. J Nurses Prof Dev (2015) 0.75
Direct care nurses' knowledge in acute myocardial infarction treatment. J Nurses Staff Dev (2012) 0.75
Engaging nurses in clinical research. Nursing (2017) 0.75